UCB Pharma Limited

208 Bath Road, Slough, Berkshire, SL1 3WE
Telephone: +44 (0)1753 534 655
Fax: +44 (0) 1773 810644
Medical Information Direct Line: +44 (0)1753 447 690
Medical Information e-mail: Medicalinformationuk@ucb.com
Customer Care direct line: +44 (0) 1773 510123
Summary of Product Characteristics last updated on the eMC: 04/11/2009
SPC Vimpat 50 mg, 100 mg, 150 mg & 200 mg film-coated tablets, 15 mg/ml syrup and 10 mg/ml solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 04/11/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
Date of revision of text on the SPC:   01-Jul-2009
Legal Category:   POM
Black Triangle (CHM):   YES

Free-text change information supplied by the pharmaceutical company

Section 6.5: Additional pack size added for solution and standard statement that not all pack sizes may be marketed.
Section 10: Updated to reflect inclusion of above in annex issued by EC.
Updated on 05/03/2009 and displayed until 04/11/2009
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   02-Feb-2009
Legal Category:   POM
Black Triangle (CHM):   YES

Free-text change information supplied by the pharmaceutical company

Section 4.4, addition of class wording regarding the monitoing of suicidal ideation and behaviours.
Section 10, updated to reflect approval of variation to include new wording in section 4.4.
Updated on 12/09/2008 and displayed until 05/03/2009
Reasons for adding or updating:
  • New SPC for new product
Date of revision of text on the SPC:  
Legal Category:   POM
Black Triangle (CHM):   YES

Free-text change information supplied by the pharmaceutical company

None provided

Active Ingredients/Generics

 
   lacosamide


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk